NRX Pharmaceuticals, Inc. (NRXP) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2024 | $0 | -100.0% |
| 2023 | $3.0K | -70.0% |
| 2022 | $10.0K | +42.9% |
| 2021 | $7.0K | +250.0% |
| 2020 | $2.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2024 | $0 | -100.0% |
| 2023 | $3.0K | -70.0% |
| 2022 | $10.0K | +42.9% |
| 2021 | $7.0K | +250.0% |
| 2020 | $2.0K | — |